-
1
-
-
0026575932
-
The mechanism of action of cyclosporin A and FK506
-
SL Schreiber GR Crabtree The mechanism of action of cyclosporin A and FK506 Immunol Today 13 1992 136 142
-
(1992)
Immunol Today
, vol.13
, pp. 136-142
-
-
Schreiber, SL1
Crabtree, GR2
-
2
-
-
0027399332
-
The skin immune system: progress in cutaneous biology
-
JD Bos ML Kapsenberg The skin immune system: progress in cutaneous biology Immunol Today 14 1993 75 78
-
(1993)
Immunol Today
, vol.14
, pp. 75-78
-
-
Bos, JD1
Kapsenberg, ML2
-
3
-
-
0027491842
-
Increased expression of epidermal IL-8 receptor in psoriasis: downregulation by FK-506 in vitro
-
BS Schulz G Michel S Wagner Increased expression of epidermal IL-8 receptor in psoriasis: downregulation by FK-506 in vitro J Immunol 151 1993 4399 4406
-
(1993)
J Immunol
, vol.151
, pp. 4399-4406
-
-
Schulz, BS1
Michel, G2
Wagner, S3
-
4
-
-
0026752175
-
Anti-inflammatory effect of FK-506 on human skin mast cells
-
A de Paulis C Stellato R Cirillo Anti-inflammatory effect of FK-506 on human skin mast cells J Invest Dermatol 99 1992 723 728
-
(1992)
J Invest Dermatol
, vol.99
, pp. 723-728
-
-
de Paulis, A1
Stellato, C2
Cirillo, R3
-
5
-
-
0030612092
-
FcϵRI expressing antigen presenting cells: new players in the atopic game
-
T Bieber FcϵRI expressing antigen presenting cells: new players in the atopic game Immunol Today 18 1997 311 313
-
(1997)
Immunol Today
, vol.18
, pp. 311-313
-
-
Bieber, T1
-
6
-
-
0030002445
-
Systemic Tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study
-
The European FK 506 Multicentre Psoriasis Study Group Systemic Tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study Arch Dermatol 132 1996 419 423
-
(1996)
Arch Dermatol
, vol.132
, pp. 419-423
-
-
The European FK 506 Multicentre Psoriasis Study Group1
-
7
-
-
4544264032
-
Inhibition of contact allergy reactions by topical FK506
-
AI Lauerma HI Maibach H Granlund Inhibition of contact allergy reactions by topical FK506 Lancet 340 1992 8818
-
(1992)
Lancet
, vol.340
, pp. 8818
-
-
Lauerma, AI1
Maibach, HI2
Granlund, H3
-
8
-
-
85056499357
-
Tacrolimus ointment for atopic dermatitis
-
H Nakagawa T Etoh Y Ishibashi Tacrolimus ointment for atopic dermatitis Lancet 344 1994 8926
-
(1994)
Lancet
, vol.344
, pp. 8926
-
-
Nakagawa, H1
Etoh, T2
Ishibashi, Y3
-
9
-
-
0028991403
-
Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment
-
H Aoyama N Tabata M Tanaka Y Uesugi H Tagami Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment Br J Dermatol 133 1995 494 496
-
(1995)
Br J Dermatol
, vol.133
, pp. 494-496
-
-
Aoyama, H1
Tabata, N2
Tanaka, M3
Uesugi, Y4
Tagami, H5
-
10
-
-
0242322394
-
A short-term trial of tacrolimus ointment for atopic dermatitis
-
T Ruzicka T Bieber E Schopf A short-term trial of tacrolimus ointment for atopic dermatitis European Tacrolimus Multicenter Atopic Dermatitis Study Group N Engl J Med 337 1997 816 821
-
(1997)
N Engl J Med
, vol.337
, pp. 816-821
-
-
Ruzicka, T1
Bieber, T2
Schopf, E3
-
11
-
-
0031657805
-
Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial
-
S Reitamo J Rissanen A Remitz Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial J Invest Dermatol 1998 In press
-
(1998)
J Invest Dermatol
-
-
Reitamo, S1
Rissanen, J2
Remitz, A3
|